Home Why Do Preclinical Humane Endpoints Matter?
 

Keywords :   


Why Do Preclinical Humane Endpoints Matter?

2015-03-13 12:15:35| drugdiscoveryonline Home Page

By Dale M. Cooper, DVM, MS, DACLAM, MPI Research When people are suffering or dying from disease, there’s a powerful incentive to move new treatments through the pipeline as quickly as possible. But while speed is important, it cannot come at the expense of quality and compliance.  The care of animals involved in preclinical safety studies is a compliance expectation by several regulatory bodies, and because the animal is the test system, good animal welfare is also good science. Establishing humane endpoints before a study begins is the right thing to do. It is an ethical expectation of the public, and it makes good business sense; humane endpoints can reveal crucial insights on a drug candidate’s mechanism of action and strengthen the rationale for a go/no-go decision.

Tags: matter humane endpoints preclinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Tropical Depression Thirteen-E Forecast Discussion Number 1
01.11Tropical Depression Thirteen-E Graphics
01.11Tropical Depression Thirteen-E Wind Speed Probabilities Number 1
01.11Summary for Tropical Depression Thirteen-E (EP3/EP132024)
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11CERM launches new MIS products, Mark Andy innovates and more
01.11Removing a major trade barrier: Full access to Colombia restored for U.S. beef
More »